ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
59 hedge funds and large institutions have $24.3M invested in Zynerba Pharmaceuticals, Inc in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
72% less call options, than puts
Call options by funds: $1.26M | Put options by funds: $4.53M
Holders
59
Holding in Top 10
–
Calls
$1.26M
Puts
$4.53M
Top Buyers
| 1 | +$1.17M | |
| 2 | +$1.17M | |
| 3 | +$795K | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$744K |
| 5 |
ECM
Element Capital Management
New York
|
+$499K |
Top Sellers
| 1 | -$4.65M | |
| 2 | -$1.62M | |
| 3 | -$1.02M | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$680K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$454K |